Injection drug use limits benefits of surgery for treatment of heart lining infection

Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers.
Source: ScienceDaily Headlines - Category: Science Source Type: news